<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07558</article-id><article-id pub-id-type="doi">10.7554/eLife.07558</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A native interactor scaffolds and stabilizes toxic Ataxin-1 oligomers in SCA1</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-31107"><name><surname>Lasagna-Reeves</surname><given-names>Cristian A</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31108"><name><surname>Rousseaux</surname><given-names>Maxime W C</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31109"><name><surname>Guerrero-Munoz</surname><given-names>Marcos J</given-names></name><aff><institution content-type="dept">Department of Neurology</institution>, <institution>University of Texas Medical Branch</institution>, <addr-line><named-content content-type="city">Galveston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31110"><name><surname>Park</surname><given-names>Jeehye</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31111"><name><surname>Jafar-Nejad</surname><given-names>Paymaan</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31112"><name><surname>Richman</surname><given-names>Ronald</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Howard Hughes Medical Institute, Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31113"><name><surname>Lu</surname><given-names>Nan</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31114"><name><surname>Sengupta</surname><given-names>Urmi</given-names></name><aff><institution content-type="dept">Department of Neurology</institution>, <institution>University of Texas Medical Branch</institution>, <addr-line><named-content content-type="city">Galveston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31115"><name><surname>Litvinchuk</surname><given-names>Alexandra</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3452"><name><surname>Orr</surname><given-names>Harry T</given-names></name><aff><institution content-type="dept">Institute for Translational Neuroscience</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minnesota</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31116"><name><surname>Kayed</surname><given-names>Rakez</given-names></name><aff><institution content-type="dept">Department of Neurology</institution>, <institution>University of Texas Medical Branch</institution>, <addr-line><named-content content-type="city">Galveston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1029"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><aff><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Howard Hughes Medical Institute, Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country><email>hzoghbi@bcm.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1073"><name><surname>De Strooper</surname><given-names>Bart</given-names></name><role>Reviewing editor</role><aff><institution>VIB Center for the Biology of Disease, KU Leuven</institution>, <country>Belgium</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>05</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e07558</elocation-id><supplementary-material><ext-link xlink:href="elife-07558-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>18</day><month>03</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>05</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Lasagna-Reeves et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Lasagna-Reeves et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Recent studies indicate that soluble oligomers drive pathogenesis in several neurodegenerative proteinopathies, including Alzheimer and Parkinson disease. Curiously, the same conformational antibody recognizes different disease-related oligomers, despite the variations in clinical presentation and brain regions affected, suggesting that the oligomer structure might be responsible for toxicity. We investigated whether polyglutamine-expanded Ataxin1, the protein that underlies spinocerebellar ataxia type 1, forms toxic oligomers and, if so, what underlies their toxicity. We found that mutant ATXN1 does form oligomers and that oligomer levels correlate with disease progression in the <italic>Atxn1<sup>154Q/+</sup></italic> mice. Moreover, oligomeric toxicity, stabilization and seeding require interaction with Capicua, which is expressed at greater ratios with respect to ATXN1 in the cerebellum than in less vulnerable brain regions. Thus, specific interactors, not merely oligomeric structure, drive pathogenesis and contribute to regional vulnerability. Identifying interactors that stabilize toxic oligomeric complexes could answer longstanding questions about the pathogenesis of other proteinopathies.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>native interactors</kwd><kwd>proteinopathies</kwd><kwd>amyloid oligomers</kwd><kwd>Ataxin 1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Huda Y Zoghbi, Senior editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#AN-1013) of Baylor College of Medicine</p></fn></fn-group></back></article>